In this issue, we present another installment of our quarterly review of dealmaking—for April-June 2006. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
The pace of pharmaceutical IPOs picked up in the quarter, with twelve deals closing compared to eight in the first...